Pyloric stenosis risk factors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
The most potent risk factors in the development of infantile pyloric stenosis are bottle-feed infant, [[Caesarean section|cesarean section]] delivery, first-born infant, preterm birth and exposure to [[Macrolide|macrolides]], [[nitrofurantoin]], [[Penicillin|penicillins]] and [[trimethoprim-sulphamethoxazole|trimethoprim-sulphamethoxazole.]] | The most potent risk factors in the development of infantile pyloric stenosis are bottle-feed infant, [[Caesarean section|cesarean section]] delivery, first-born infant, preterm birth and exposure to [[Macrolide|macrolides]], [[nitrofurantoin]], [[Penicillin|penicillins]] and [[trimethoprim-sulphamethoxazole|trimethoprim-sulphamethoxazole during pregnancy.]] | ||
==Risk Factors== | ==Risk Factors== | ||
=== Risk Factors for infantile pyloric stenosis | === Risk Factors for infantile pyloric stenosis=== | ||
*Bottle-feed infant | *Bottle-feed infant | ||
| Line 15: | Line 13: | ||
*First-born infant | *First-born infant | ||
*Preterm birth | *Preterm birth | ||
*Exposure to [[Macrolide|macrolides]], [[nitrofurantoin]], [[Penicillin|penicillins]] and [[trimethoprim-sulphamethoxazole]]<ref name="pmid26905846">{{cite journal| author=Nordeng S, Nordeng H, Høye S| title=[Use of antibiotics during pregnancy]. | journal=Tidsskr Nor Laegeforen | year= 2016 | volume= 136 | issue= 4 | pages= 317-21 | pmid=26905846 | doi=10.4045/tidsskr.15.0451 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26905846 }} </ref> | *Exposure to [[Macrolide|macrolides]], [[nitrofurantoin]], [[Penicillin|penicillins]] and [[trimethoprim-sulphamethoxazole|trimethoprim-sulphamethoxazole during pregnancy]]<ref name="pmid26905846">{{cite journal| author=Nordeng S, Nordeng H, Høye S| title=[Use of antibiotics during pregnancy]. | journal=Tidsskr Nor Laegeforen | year= 2016 | volume= 136 | issue= 4 | pages= 317-21 | pmid=26905846 | doi=10.4045/tidsskr.15.0451 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26905846 }} </ref><ref name="pmid26905846" /> | ||
=== Risk Factors for adult-onset hypertrophic pyloric stenosis (HPS) | === Risk Factors for adult-onset hypertrophic pyloric stenosis (HPS)=== | ||
There is no established | There is no established risk factor for adult-onset hypertrophic pyloric stenosis (HPS). | ||
==References== | ==References== | ||
Revision as of 14:37, 30 October 2017
|
Pyloric stenosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pyloric stenosis risk factors On the Web |
|
American Roentgen Ray Society Images of Pyloric stenosis risk factors |
|
Risk calculators and risk factors for Pyloric stenosis risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamadmostafa Jahansouz M.D.[2]
Overview
The most potent risk factors in the development of infantile pyloric stenosis are bottle-feed infant, cesarean section delivery, first-born infant, preterm birth and exposure to macrolides, nitrofurantoin, penicillins and trimethoprim-sulphamethoxazole during pregnancy.
Risk Factors
Risk Factors for infantile pyloric stenosis
- Bottle-feed infant
- Cesarean section delivery
- First-born infant
- Preterm birth
- Exposure to macrolides, nitrofurantoin, penicillins and trimethoprim-sulphamethoxazole during pregnancy[2][2]
Risk Factors for adult-onset hypertrophic pyloric stenosis (HPS)
There is no established risk factor for adult-onset hypertrophic pyloric stenosis (HPS).
References
- ↑ Zhu J, Zhu T, Lin Z, Qu Y, Mu D (2017). "Perinatal risk factors for infantile hypertrophic pyloric stenosis: A meta-analysis". J Pediatr Surg. 52 (9): 1389–1397. doi:10.1016/j.jpedsurg.2017.02.017. PMID 28318599.
- ↑ 2.0 2.1 Nordeng S, Nordeng H, Høye S (2016). "[Use of antibiotics during pregnancy]". Tidsskr Nor Laegeforen. 136 (4): 317–21. doi:10.4045/tidsskr.15.0451. PMID 26905846.